MAGGIO J; ARMANDO RG,; BALCONE L; VILARULLO, ROMAN; CASCO MDP; MENGUAL GOMEZ DL,; GOMEZ DE

127 Role of PIN1 in human pathology: Cellular regulation, pathogenesis and therapeutic implications

World Academy of Sciences Journal; Año: 2023 vol. 6

MAGGIO J; CARDAMA GA; BALCONE L; SOBOL N; GOMEZ DE; MENGUAL GOMEZ DL,

Key role of PIN1 in telomere maintenance and oncogenic behavior in a human glioblastoma model

ONCOLOGY REPORTS; Lugar: Atenas; Año: 2023

ARMANDO, ROMINA; CABRERA, MAIA; VILARULLO, ROMAN; CHINESTRAD, PATRICIO; MAGGIO, JULIAN; PADERTA, CAMILA; LORENZANO MENNA, PABLO; GOMEZ, DANIEL; MENGUAL GÓMEZ, DIEGO

In vitro characterization and rational analog design of a novel inhibitor of telomerase assembly in MDA MB 231 breast cancer cell line

Oncology reports; Año: 2022 vol. 48

CARDAMA GA; MAGGIO J; LUCAS VALDEZ CAPPUCCINO; N GONZALEZ; VALENTINA MATILLER; ORTEGA H; GERMAN PEREZ; IGNACIO A DEMARCO; EDUARDO SPITZER; D.E. GOMEZ; LORENZANO MENA P; DANIEL F ALONSO

Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models

Cancers; Año: 2022

CASTILLO A; ORLANDO UD; MALOBERTI PM; PRADA J; DATTILO M; SOLANO AR; BIGI M; RIOS MEDRANO M; TORRES M; INDO S; CAROCA G; CONTRERAS H; MARELLI B; SALINAS F; SALVETTI N; ORTEGA H; LORENZANO MENNA P; SZAJNMAN S; GOMEZ, DANIEL EDUARDO; RODRIGUEZ J; PODESTA E

New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis

Cellular and Molecular Life Sciences; Año: 2021

MAGGIO J; CABRERA M; ARMANDO RG,; CHINESTRAD P; MARINA PIFANO; LORENZANO MENNA P; GOMEZ, DANIEL EDUARDO; MENGUAL GOMEZ DL,

Rational design of PIN1 inhibitors for cancer treatment based on conformational diversity analysis and docking based virtual screening

Journal of Biomolecular Structure and Dynamics; Año: 2021

N GONZALEZ; CARDAMA GA; CHINESTRAD P; ROBLES-VALERO J; RODRIGUEZ FERNANDEZ F; MARTIN L; FRANCISCO L; BUSTELO X; LORENZANO MENA P; GOMEZ, DANIEL EDUARDO

Computational and in vitro Pharmacodynamics Characterization of 1A-116 Rac1 Inhibitor: Relevance of Trp56 in Its Biological Activity

Frontiers in Cell and Developmental Biology; Año: 2020

ARMANDO RG,; MENGUAL GOMEZ DL,; GOMEZ, DANIEL EDUARDO

New drugs are not enough-drug repositioning in oncology

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Atenas; Año: 2020 vol. 56

GARONA, J.; SOBOL N; MARINA PIFANO; SEGATORI VI; D.E. GOMEZ; GISELLE V RIPOLL; 2006: G.V. RIPOLL, H.G. FARINA, D.E. GOMEZ, D.F. ALONSO.

[V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; Lugar: Basel; Año: 2019

ARMANDO RG; MENGUAL GOMEZ DL,; MAGGIO J; SANMARTIN C; D.E. GOMEZ

Telomeropathies: Etiology, diagnosis, treatment and follow-up. Ethical and legal considerations.

CLINICAL GENETICS; Lugar: Londres; Año: 2019

ARMANDO RG,; MENGUAL GOMEZ DL; JURITZ E; LORENZANO MENNA P; GOMEZ DE

Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; Lugar: Basel; Año: 2018

CARDAMA GA; ALONSO DF; N GONZALEZ; MAGGIO J; D.E. GOMEZ; ROLFO C; LORENZANO MENNA P

Relevance of small GTPase Rac1 pathway in drug and radio-resistance mechanisms: Opportunities in cancer therapeutics.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; Lugar: Amsterdam; Año: 2018 vol. 124 p. 497 - 504

N. GONZALEZ; G.A. CARDAMA; M.J. COMIN; V.I. SEGATORI; M. PIFANO ; ALONSO DF; D.E. GOMEZ; LORENZANO MENNA P

Pharmacological inhibition of Rac1-PAK1 axis restores tamoxifen sensitivity in human resistant breast cancer cells

CELLULAR SIGNALLING; Lugar: Amsterdam; Año: 2017 vol. 30 p. 154 - 161

CARDAMA GA; N GONZALEZ; MAGGIO J; LORENZANO MENNA P; D.E. GOMEZ

Rho GTPases as therapeutic targets in cancer.

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Atenas; Año: 2017

MAGGIO J; N GONZALEZ; G.A. CARDAMA; D.E. GOMEZ

Rho GTPases as molecular targets in cancer. Strategies and therapeutic opportunities

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2017 vol. 77 p. 497 - 504

MENGUAL GOMEZ DL, ; ARMANDO RG; CERRUDO CS; GHIRINGHELLI PD,; GOMEZ DE.

Telomerase as a cancer target. Development of new molecules.

Current Topics in Medicinal Chemistry; Lugar: Oak Park; Año: 2016 vol. 16 p. 2432 - 2440

ARMANDO RG; MENGUAL GOMEZ DL,; D.E. GOMEZ

AZT exerts its antitumoral effect by telomeric and non-telomeric effects in a mammary adenocarcinoma model

ONCOLOGY REPORTS; Lugar: Atenas; Año: 2016 vol. 36 p. 2731 - 2736

GARONA J ; PIFANO M; PASTRIAN MB; GOMEZ DE; RIPOLL GV; ALONSO DF

Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.

CLINICAL & EXPERIMENTAL METASTASIS; Lugar: Berlin; Año: 2016 vol. 33 p. 589 - 600

CERRUDO C; MENGUAL GOMEZ DL; D.E. GOMEZ; GHIRINGHELLI PD

Novel insights into the evolution and structural characterization of dyskerin using comprehensive bioinformatics analysis.

JOURNAL OF PROTEOME RESEARCH; Lugar: Washington; Año: 2015 vol. 6 p. 874 - 877

D.E. GOMEZ

Research, intellectual property and development. Its implications for Argentine science

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2015 vol. 75 p. 62 - 64

FERNANDEZ LARROSA P; RUIZ GRECCO M; MENGUAL GOMEZ DL; ALVARADO CV; PANELO LC; RUBIO MF; ALONSO DF; D.E. GOMEZ; COSTAS MA

RAC3 more than a nuclear receptor coactivator: A key inhibitor of senescence that is down-regulated in aging.

Cell Death and Disease; Lugar: New York; Año: 2015

WEINBERG RUTH; GRECCO MARCELO; GIMENA S FERRO; DEBORA J SEIGELSHIFER; NANCY V PERRONI; FRANCISCO J TERRIER; ANALÍA SÁNCHEZLUCEROS; ESTEBAN MARONNA; RICARDO SÁNCHEZ-MARUL; ISABEL FRAHM; MARCELO D GUTHMANN; DANIELA DI LEO; EDUARDO SPITZER; GRACIELA N CICCIA; JUAN GARONA; MARINA PIFANO; ANA V TORBIDONI; DANIEL GOMEZ; GISELLE V RIPOLL; ROBERTO E GOMEZ; IGNACIO A DEMARCO; DANIEL F ALONSO

. A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-D-arginine vasopressin) in breast cancer patients R.S. Weinberg, M.O. Grecco, G.S. Ferro, D.J. Seigelshifer, N.V. Perroni, F.J. Terrier, A. Sanchez Luceros, E. Maronna, R. Sanc

SpringerPlus; Lugar: Londres; Año: 2015 vol. 4 p. 428 - 433

GARONA, J. ; PIFANO M; ORLANDO UD; PASTRIAN MB; IANUCCI NB; ORTEGA H; PODESTA EJ; D.E. GOMEZ; G.V. RIPOLL,; ALONSO DF

The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Atenas; Año: 2015 vol. 46 p. 2335 - 2345

CERRUDO C; GHIRINGHELLI PD; GOMEZ DE

Protein Universe Containing a PUA RNA binding domain

FEBS JOURNAL; Lugar: Londres; Año: 2014

PASTRIAN MB; GUZMAN F; GARONA J; PIFANO M; RIPOLL GV; CASCONE O; CICCIA G; ALBERICIO; GOMEZ DE; ALONSO DF; IANUCCI NB

Structure activity relationship of 1 desamino 8 D arginine vasopressin as an antiproliferative agent on human V2 receptor expressing cancer cells

MOLECULAR MEDICINE REPORTS; Lugar: Atenas; Año: 2014 p. 2568 - 2572

MENGUAL GOMEZ DL; ARMANDO RG; FARINA HG; GOMEZ DE

TELOMERASA Y TELÓMERO: SU ESTRUCTURA Y DINÁMICA EN SALUD Y ENFERMEDAD

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2014 vol. 74 p. 69 - 76

BENAVENT ACERO, F. R. PERERA NEGRIN, Y. ALONSO, D. F. PEREA, S. E. GOMEZ, D. E. FARINA, H. G.

Mechanisms of cellular uptake, intracellular transportation, and degradation of CIGB-300, a Tat-conjugated peptide, in tumor cell lines

MOLECULAR PHARMACEUTICS; Año: 2014 vol. 11 p. 1798 - 1807

GARONA, J. PIFANO, M. SCURSONI, A. M. GOMEZ, D. E. ALONSO, D. F. RIPOLL, G. V.

Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice

ANTICANCER RESEARCH; Año: 2014 vol. 34 p. 4761 - 4765

CARDAMA GA; N GONZALEZ; M CIARLANTINI; L GANDOLFI DONADÍO; DF ALONSO ; LORENZANO MENNA P; D.E. GOMEZ

Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells

Journal of Oncotargets and Therapy; Año: 2014 vol. 7 p. 2021 - 2033

RIPOLL GV; GARONA J; PIFANO M; FARINA HG; GOMEZ DE; ALONSO DF

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 2013 vol. 142 p. 9 - 18

GOMEZ DL; FARINA HG; GOMEZ DE

Telomerase regulation: a key to inhibition? (Review)

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Atenas; Año: 2013 vol. 43 p. 1351 - 1356

GOMEZ DE; VAZQUEZ AM; ALONSO DF; MACIAS A

Antiidiotype antibodies in cancer treatment.

Frontiers in Oncology; Lugar: Washingnton; Año: 2013 vol. 3 p. 1 - 2

CARDAMA, G. A. COMIN, M. J. HORNOS, L. GONZALEZ, N. DEFELIPE, L. TURJANSKI, A. G. ALONSO, D. F. GOMEZ, D. E. MENNA, P. L.

Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY; Año: 2013 vol. 14 p. 840 - 851

GOMEZ DE; VAZQUEZ AM; ALONSO DF; MACIAS A

Antiidiotype antibodies in cancer treatment.

Frontiers in Oncology; Lugar: Washingnton; Año: 2013 vol. 3 p. 1 - 2

CARDOZO AJ; GOMEZ DE; ARGIBAY PF

Neurogenic differentiation of human adipose derived stem cells : Relevance of different signaling molecules, transcription factors, and key marker genes.

GENE; Lugar: Amsterdam; Año: 2012 vol. 511 p. 427 - 436

VAZQUEZ AM; HERNANDEZ AM; MACIAS A; MONTERO E; GOMEZ DE; ALONSO DF; GABRI MR; GOMEZ RE

Racotumomab: an anti=idiotype vaccine related to N=glycolyl=containing=gangliosides. Preclinical and clinical data.

Frontiers in Oncology; Lugar: Washingnton; Año: 2012 vol. 2 p. 1 - 6

GOMEZ DE; ARMANDO RG; ALONSO DF

AZT as a telomerase inhibitor

Frontiers in Oncology; Lugar: Washingnton; Año: 2012 vol. 2 p. 1 - 5

GOMEZ DE; ARMANDO RG; FARINA HG; LORENZANO MENNA P; CERRUDO C; GHIRINGHELLI PD; ALONSO DF

Telomerase structure and telomerase in health and disease

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Atenas; Año: 2012 vol. 41 p. 1561 - 1569

GOMEZ DE; VAZQUEZ AM; ALONSO DF

Cancer antigen prioritization: a road map to work in defining vaccines against specific targets. A point of view.

Frontiers in Oncology; Lugar: Washingnton; Año: 2012 vol. 2 p. 66 - 66

PERERA Y; COSTALES HC; DIAZ Y; REYES O; FARINA HG; MENDEZ L; GOMEZ RE; ACEVEDO BE; GOMEZ DE; ALONSO DF; PEREA SE

Sensitivity of tumor cells towards CIGB-300 ANTICANCER PEPTIDE RELIES ON ITS NUCLEOLAR LOCALIZATION.

JOURNAL OF PEPTIDE SCIENCE : AN OFFICIAL PUBLICATION OF THE EUROPEAN PEPTIDE SOCIETY.; Lugar: LOndres; Año: 2012 vol. 4 p. 215 - 223

SEGATORI VI; VAZQUEZ AM; GOMEZ DE; GABRI MR; ALONSO DF

Preclinical evaluation of racotumomab, an anti=idiotype monoclonal antibody to NGlicolyl containing gangliosides, with or without chemotherapy in a mouse model of non small cell lung cancer

Frontiers in Oncology; Lugar: Washingnton; Año: 2012 vol. 2 p. 1 - 7

ORLANDO UD; GARONA J; RIPOLL GV; MALOBERTI PM; SOLANO AR; AVAGNINA DE; GOMEZ DE; ALONSO DF; PODESTA EJ

The functional interaction between acyl-CoA synthetase 4, 5-lypooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target

PLOS ONE; Lugar: San Francisco; Año: 2012 p. 1 - 14

SEGATORI VI; OTERO LL; FERNANDEZ LE; GOMEZ DE; ALONSO DF; GABRI MR

Antitumor protection by NGcGM3/VSSP vaccine against transfected B16 mouse melanoma cells overexpressing N-Glycolylated gangliosides.

IN VIVO; Lugar: Atenas; Año: 2012 vol. 26 p. 609 - 617

SEGATORI VI; VAZQUEZ AM; GOMEZ DE; GABRI MR; ALONSO DF

Preclinical evaluation of racotumomab, an anti=idiotype monoclonal antibody to NGlicolyl containing gangliosides, with or without chemotherapy in a mouse model of non small cell lung cancer

Frontiers in Oncology; Lugar: Washingnton; Año: 2012 vol. 2 p. 1 - 7

VAZQUEZ AM; HERNANDEZ AM; MACIAS A; MONTERO E; GOMEZ DE; ALONSO DF; GABRI MR; GOMEZ RE

Racotumomab: an anti=idiotype vaccine related to N=glycolyl=containing=gangliosides. Preclinical and clinical data.

Frontiers in Oncology; Lugar: Washingnton; Año: 2012 vol. 2 p. 1 - 6

GOMEZ DE; ARMANDO RG; ALONSO DF

AZT as a telomerase inhibitor

Frontiers in Oncology; Lugar: Washingnton; Año: 2012 vol. 2 p. 1 - 5

GOMEZ DE; VAZQUEZ AM; ALONSO DF

Cancer antigen prioritization: a road map to work in defining vaccines against specific targets. A point of view.

Frontiers in Oncology; Lugar: Washingnton; Año: 2012 vol. 2 p. 66 - 66

HERMO G; TURIC E; ANGELICO D; SCURSONI AM; GOMEZ DE; GOBELLO C; ALONSO DF

Effect of adjuvant perioperative desmopressin in locally advanced canince mammary carcinoma and its relation to histologic grade

Journal of the American Animal Hospital Association; Año: 2011 p. 21 - 27

HERMO G; TURIC E; ANGELICO D; SCURSONI AM; GOMEZ DE; GOBELLO C; ALONSO DF

Effect of adjuvant perioperative desmopressin in locally advanced canince mammary carcinoma and its relation to histologic grade

JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION; Año: 2011 p. 21 - 27

IANUCCI NB; RIPOLL GV; GARONA J; CASCONE O; CICCIA G; GOMEZ DE; ALONSO DF

Antiproliferative effect of 1-deamino-8-D-arginine vasopressin analogs on human breast cancer cells

Future Medicinal Chemistry; Año: 2011 p. 1987 - 1993

PEREA SE; BALADRON I; GARCIA Y; PERERA Y; LOPEZ A; SORIANO JL; BATISTA N; PALAU A; HERNANDEZ I ; FARINA HG; GARCIA I; GONZALEZ L; GIL J; RODRIGUEZ A; SOLARES M; SANTANA A; CRUZ M; LOPEZ M; VALENZUELA C; REYES O; LOPEZ-SAURA PA; GONZALEZ CA; DIAZ A; CASTELLANOS L; SANCHEZ A; BETANCOURT L; BESADA V; GONZALEZ LJ; GARAY H; GOMEZ R; GOMEZ DE; ALONSO DF; PERRIN P; RENAULT JY; SIGMAN H; HERRERA L; ACEVEDO BE

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research.

MOLECULAR AND CELLULAR BIOCHEMISTRY; Año: 2011 p. 45 - 50

ALONSO DF; RIPOLL GV; GARONA J; IANUCCI N; GOMEZ DE

Metastasis: Recent Discoveries and Novel Perioperative Treatment Strategies with Particular Interest in the Hemostatic Compound Desmopressin

CURRENT PHARMACEUTICAL BIOTECHNOLOGY; Año: 2011

HERMO G; FARINA GV; ALONSO DF; GOMEZ DE

Effect of atorvastatin in a case of feline multicentric lymphoma-Case report.

ACTA VETERINARIA HUNGARICA; Año: 2011 p. 69 - 77

OTERO L; ALONSO DF; CASTRO M; CINAT G; GABRI MR; GOMEZ DE

Tissue factor as a novel marker for detection of circulating cancer cells.

BIOMARKERS; Año: 2011 p. 58 - 64

PELLEGRINI ML; ARGIBAY P; GOMEZ DE

Genetic and epigenetic of colorectal cancer

ACTA GASTROENTEROLOGICA LATINOAMERICANA.; Año: 2011 p. 247 - 261

CARDOZO AJ; GOMEZ DE; ARGIBAY

Transcriptional characterization of Wnt and Notch signaling pathways in neuronal differentiation of human adipose tissue-derived stem cells.

J Mol Neurosci; Año: 2011 p. 9503 - 9509

FARINA HG; BENAVENT ACERO F; PERERA Y; RODRIGUEZ A; PEREA SE; ACEVEDO BE; GOMEZ RE; ALONSO DF; GOMEZ DE

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo.

EXPERIMENTAL CELL RESEARCH; Año: 2011 p. 1677 - 1688

IANUCCI NB; RIPOLL GV; GARONA J; CASCONE O; CICCIA G; GOMEZ DE; ALONSO DF

Antiproliferative effect of 1-deamino-8-D-arginine vasopressin analogs on human breast cancer cells

Future Medicinal Chemistry; Año: 2011 p. 1987 - 1993

CARDOZO AJ; GOMEZ DE; ARGIBAY

Transcriptional characterization of Wnt and Notch signaling pathways in neuronal differentiation of human adipose tissue-derived stem cells.

J Mol Neurosci; Año: 2011 p. 9503 - 9509

RIPOLL GV; GARONA J; HERMO G; GOMEZ DE; ALONSO DF

Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancer.

ANTICANCER RESEARCH; Año: 2010 p. 5049 - 5052

PELLEGRINI ML; ARGIBAY P; GOMEZ DE

Dietary factors, genetic and epigenetic influences in colorectal cancer (Review)

Experimental and Therapeutic Medicine; Año: 2010 p. 241 - 250

LORENZANO MENNA P; CARDAMA GA; COMIN MJ; ALONSO DF; GOMEZ DE

Rho GTPases as therapeutic targets in cancer and other human diseases

MEDICINA (BUENOS AIRES); Año: 2010 p. 555 - 564

CARDOZO AJ; IELPI M; GOMEZ DE; ARGIBAY P

Differential expression of Shh and BMP signaling in the potential conversion of human adipose tissue stem cells into neuron-like cells in vitro.

GENE EXPRESSION; Año: 2010 p. 307 - 319

PELLEGRINI ML; ARGIBAY P; GOMEZ DE

Dietary factors, genetic and epigenetic influences in colorectal cancer (Review)

Experimental and Therapeutic Medicine; Año: 2010 p. 241 - 250

FERNANDEZ LE; GABRI MR; GUTHMANN MD; GOMEZ RE; GOLD S; FAINBOIM L; GOMEZ DE; ALONSO DF

NGcGM• ganglioside: a privileged target for cáncer vaccines.

CLINICAL AND DEVELOPMENTAL IMMUNOLOGY; Año: 2010 p. 814397 - 814398

PABLO LORENZANO MENNA, ROMINA L. PARERA1, GEORGINA A. CARDAMA, DANIEL F. ALONSO, DANIEL E. GOMEZ AND HERNAN G. FARINA

Enhanced cytostatic activity of statins in mouse mammary carcinoma cells overexpressing ß2-chimaerin

MOLECULAR MEDICINE REPORTS; Lugar: Atenas; Año: 2009 vol. 2 p. 97 - 102

VALERIA VAZQUEZ, LAURA L. OTERO, VIVIANA E. LAURENT, MARIANO R. GABRI, DANIEL E. GOMEZ, DANIEL F. ALONSO

DETECCIÓN MOLECULAR DE ENFERMEDAD MÍNIMA RESIDUAL EN MELANOMA Y OTROS TUMORES SÓLIDOS

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2009 vol. 69 p. 181 - 190

MARIANO R GABRI*†, LAURA L OTERO†, DANIEL E GOMEZ AND DANIEL F ALONSO

Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH; Lugar: Roma; Año: 2009 vol. 28 p. 1 - 8

GISELLE V. RIPOLL, SANTIAGO GIRON, MARTIN J. KRZYMUSKI, GUILLERMO A. HERMO, DANIEL E. GOMEZ AND DANIEL F. ALONSO

Antitumor Effects of Desmopressin in Combination with Chemotherapeutic Agents in a Mouse Model of Breast Cancer

ANTICANCER RESEARCH; Lugar: Atenas; Año: 2008 vol. 28 p. 2607 - 2612

GUILLERMO A. HERMO A,*, PERLA TORRES B, GISELLE V. RIPOLL A, ALEJANDRA M. SCURSONI A,D, DANIEL E. GOMEZ A, DANIEL F. ALONSO A, CRISTINA GOBELLO C

Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: A pilot study

The Veterinary Journal; Lugar: New York; Año: 2008 vol. 178 p. 103 - 108

S PEREA ...H FARINA.....D GOMEZ R GOMEZ D ALONSO H SIGMAN L HERRERA B ACEVEDO

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo.

MOLECULAR AND CELLULAR BIOCHEMISTRY; Lugar: New York; Año: 2008 vol. 316 p. 163 - 167

GABRI MR, VASQUEZ V, GIRON S, CASTRO MA, CINAT G, GOMEZ RE, SANTORO FM, GOMEZ DE, ALONSO DF

Molecular detection of circulating tyrosinase mRNA: Optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patients.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Lugar: Atenas; Año: 2008 vol. 21 p. 555 - 559

PERERA Y, FARINA HG, HERNÁNDEZ I, MENDOZA O, SERRANO JM, REYES O, GÓMEZ DE, GÓMEZ RE, ACEVEDO BE, ALONSO DF, PEREA SE.

Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice.

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: Hoboken, New Jersey, USA; Año: 2008 vol. 122 p. 57 - 62

GOMEZ DE, RIPOLL GV, GIRÓN S, ALONSO DF.

Desmopressin and other synthetic vasopressin analogues in cancer treatment.

Bull Cancer; Año: 2006 vol. 93 p. 7 - 12

GABRI MR, MAZORRA Z, RIPOLL GV, MESA C, FERNANDEZ LE, GOMEZ DE, ALONSO DF.

Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma model.

Clin Cancer Res; Año: 2006 vol. 12 p. 7092 - 7098

HG FARINA, M POMIES, DF ALONSO, DE GOMEZ

Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer

ONCOLOGY REPORTS; Lugar: Atenas; Año: 2006 vol. 16 p. 885 - 891

RIPOLL GV, FARINA HG, YOSHIJI H, GOMEZ DE, ALONSO DF.

Desmopressin reduces melanoma lung metastasis in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1.

IN VIVO; Año: 2006 vol. 20 p. 881 - 885

GOMEZ DE, RIPOLL GV, GIRÓN S, ALONSO DF.

Desmopressin and other synthetic vasopressin analogues in cancer treatment.

Bull Cancer; Año: 2006 vol. 93 p. 7 - 12

GABRI MR, MAZORRA Z, RIPOLL GV, MESA C, FERNANDEZ LE, GOMEZ DE, ALONSO DF.

Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma model.

Clin Cancer Res; Año: 2006 vol. 12 p. 7092 - 7098

PABLO LORENZANO MENNA , LETICIA Y. PECHE, DANIEL F. ALONSO , DANIEL E. GOMEZ

Role of B2 chimaerin in the behaviour of murine mammary carcinoma cells in response toextracellular matrix components

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Lugar: Athenas; Año: 2005 vol. 15 p. 91 - 95

DE LORENZO, M. S. FARINA, H. G. ALONSO, D. F. GOMEZ, D. E.

Role of protein kinase C-dependent signaling pathways in the antiangiogenic properties of nafoxidine

ANTICANCER RESEARCH; Año: 2004 vol. 24 p. 1737 - 1743

FERNANDEZ, LUIS E ALONSO, DANIEL F GOMEZ, DANIEL E VAZQUEZ, ANA M

Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer

EXPERT REVIEW OF VACCINES; Año: 2004 vol. 2 p. 817 - 823

DE GOMEZ , GV RIPOLL , S GIRON , DF ALONSO

Potential application of desmopressin as a perioperative adjuvant in cancer surgery. Biological effects, antitumor porperties and clinical usefulness

Cancer Therapy; Año: 2004 vol. 2 p. 279 - 290

MD GUTMAN, RJ BITTON, AJL CARNERO, MR GABRI, G CINAT, L KOLIREN, D LEWI, LE FERNANDEZ , DF ALONSO, DE GOMEZ, L FAINBOIM

Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine

J Immunother; Año: 2004 vol. 27 p. 442 - 451

M YAMAZAKI, T AKAHANE, T BUCK, H YOSHIJI, DE GOMEZ , DJ SHOEEFFNER, E OKAJIMA, SR HARRIS, OR BUNCE, SS THORGEIRSSON , UP THORGEIRSSON

Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice

CARCINOGENESIS; Año: 2004 vol. 25 p. 1735 - 1746

DE GOMEZ , GV RIPOLL , S GIRON , DF ALONSO

Potential application of desmopressin as a perioperative adjuvant in cancer surgery. Biological effects, antitumor porperties and clinical usefulness

Cancer Therapy; Año: 2004 vol. 2 p. 279 - 290

MD GUTMAN, RJ BITTON, AJL CARNERO, MR GABRI, G CINAT, L KOLIREN, D LEWI, LE FERNANDEZ , DF ALONSO, DE GOMEZ, L FAINBOIM

Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine

J Immunother; Año: 2004 vol. 27 p. 442 - 451

MENNA, P. L. SKILTON, G. LESKOW, F. C. ALONSO, D. F. GOMEZ, D. E. KAZANIETZ, M. G.

Inhibition of aggressiveness of metastatic mouse mammary carcinoma cells by the beta2-chimaerin GAP domain

CANCER RESEARCH; Año: 2003 vol. 63 p. 2284 - 2291

DE LORENZO, M. S. RIPOLL, G. V. YOSHIJI, H. YAMAZAKI, M. THORGEIRSSON, U. P. ALONSO, D. F. GOMEZ, D. E

Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1

IN VIVO; Año: 2003 vol. 17 p. 40 - 45

BITTON, R. J. GUTHMANN, M. D. GABRI, M. R. CARNERO, A. J. ALONSO, D. F. FAINBOIM, L. GOMEZ, D. E.

Cancer vaccines: an update with special focus on ganglioside antigens

ONCOLOGY REPORTS; Año: 2002 vol. 9 p. 267 - 276

GIRON, SANTIAGO TEJERA, AGUEDA M RIPOLL, GISELLE V GOMEZ, DANIEL E ALONSO, DANIEL F

Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation

JOURNAL OF SURGICAL ONCOLOGY; Año: 2002 vol. 81 p. 38 - 44

GABRI, M. R. RIPOLL, G. V. ALONSO, D. F. GOMEZ, D. E.

Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; Lugar: Berlin; Año: 2002 vol. 128 p. 669 - 677

FARINA, HERNAN G BUBLIK, DEBORA R ALONSO, DANIEL F GOMEZ, DANIEL E

Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells

CLINICAL & EXPERIMENTAL METASTASIS; Lugar: Berlin; Año: 2002 vol. 19 p. 551 - 559

YOSHII, J YOSHIJI, H KURIYAMA, S IKENAKA, Y NOGUCHI, R OKUDA, H TSUJINOUE, H NAKATANI, T KISHIDA, H NAKAE, D GOMEZ, D E DE LORENZO, M S TEJERA, A M FUKUI, H

The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 2001 vol. 9 p. 768 - 773

DE LORENZO, M S LORENZANO MENNA, P L ALONSO, D F GOMEZ, D E

In vitro activity of a Solanum tuberosum extract against mammary carcinoma cells

PLANTA MEDICA; Año: 2001 vol. 67 p. 164 - 166

TEJERA, A. M. ALONSO, D. F. GOMEZ, D. E. OLIVERO, O. A.

Chronic in vitro exposure to 3'-azido-2', 3'-dideoxythymidine induces senescence and apoptosis and reduces tumorigenicity of metastatic mouse mammary tumor cells

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 2001 vol. 65 p. 93 - 99

CERRUDO C; MENGUAL GOMEZ DL; D.E. GOMEZ; GHIRINGHELLI PD

Novel Insights into the evolution and structural characterization of dyskerin using comprehensive bioinformatic analysis.

JOURNAL OF PROTEOME RESEARCH; Lugar: Washington; Año: 2001 vol. 14 p. 874 - 887

YOSHIJI, H KURIYAMA, S MIYAMOTO, Y THORGEIRSSON, U P GOMEZ, D E KAWATA, M YOSHII, J IKENAKA, Y NOGUCHI, R TSUJINOUE, H NAKATANI, T THORGEIRSSON, S S FUKUI, H

Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model

HEPATOLOGY (BALTIMORE, MD.); Año: 2000 vol. 32 p. 1248 - 1254

VAZQUEZ, A. M. GABRI, M. R. HERNANDEZ, A. M. ALONSO, D. F. BEAUSOLEIL, I. GOMEZ, D. E. PEREZ, R.

Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides

ONCOLOGY REPORTS; Año: 2000 vol. 7 p. 751 - 756

DE LORENZO, M S ALONSO, D F GOMEZ, D E

Nafoxidine modulates the expression of matrix-metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in endothelial cells

ANTICANCER RESEARCH; Año: 2000 vol. 20 p. 395 - 400

GABRI, M. R. MENNA, P. L. SCURSONI, A. M. GOMEZ, D. E. ALONSO, D. F

Role of tumor-derived granulocyte-macrophage colony-stimulating factor in mice bearing a highly invasive and metastatic mammary carcinoma

PATHOBIOLOGY; Año: 2000 vol. 67 p. 180 - 185

ALONSO, D F SKILTON, G FARIAS, E F BAL DE KIER JOFFE, E GOMEZ, D E

Antimetastatic effect of desmopressin in a mouse mammary tumor model

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 2000 vol. 57 p. 271 - 275

CARR, A. MAZORRA, Z. ALONSO, D. F. MESA, C. VALIENTE, O. GOMEZ, D. E. PEREZ, R. FERNANDEZ, L. E.

A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo

MELANOMA RESEARCH.; Lugar: Philadelphia; Año: 2000 vol. 11 p. 219 - 227

GOMEZ, D. E. SKILTON, G. ALONSO, D. F. KAZANIETZ, M. G.

The role of protein kinase C and novel phorbol ester receptors in tumor cell invasion and metastasis (Review)

ONCOLOGY REPORTS; Año: 1999 vol. 6 p. 1363 - 1370

GOMEZ, D. E. DE LORENZO, M. S. ALONSO, D. F. ANDRADE, Z. A.

Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE; Año: 1999 vol. 61 p. 9 - 13

ALONSO, D F FARINA, H G ARREGUI, C AON, M A GOMEZ, D E

Modulation of urokinase-type plasminogen activator and metalloproteinase activities in cultured mouse mammary-carcinoma cells: enhancement by paclitaxel and inhibition by nocodazole

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 1999 vol. 83 p. 242 - 246

ALONSO, D F TEJERA, A M FARIAS, E F BAL DE KIER JOFFE, E GOMEZ, D E

Inhibition of mammary tumor cell adhesion, migration, and invasion by the selective synthetic urokinase inhibitor B428

ANTICANCER RESEARCH; Año: 1999 vol. 18 p. 4499 - 4505

ALONSO, D. F. GABRI, M. R. GUTHMANN, M. D. FAINBOIM, L. GOMEZ, D. E.

A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma

INTERNATIONAL JOURNAL OF ONCOLOGY; Año: 1999 vol. 15 p. 59 - 66

AGUIRRE GHISO, J A ALONSO, D F FARIAS, E F GOMEZ, D E DE KIER JOFFE, E B

Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype

EUROPEAN JOURNAL OF BIOCHEMISTRY; Año: 1999 vol. 263 p. 294 - 304

ALONSO, D F TEJERA, A M FARIAS, E F BAL DE KIER JOFFE, E GOMEZ, D E

Inhibition of mammary tumor cell adhesion, migration, and invasion by the selective synthetic urokinase inhibitor B428

ANTICANCER RESEARCH; Año: 1999 vol. 18 p. 4499 - 4504

GOMEZ, D E TEJERA, A M OLIVERO, O A

Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; Año: 1998 vol. 246 p. 107 - 110

OSHIJI, H. HARRIS, S. R. RASO, E. GOMEZ, D. E. LINDSAY, C. K. SHIBUYA, M. SINHA, C. C. THORGEIRSSON, U. P.

Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 1998 vol. 75 p. 81 - 87

ALONSO, D. F. SKILTON, G. DE LORENZO, M. S. SCURSONI, A. M. YOSHIJI, H. GOMEZ, D. E.

Histopathological findings in a highly invasive mouse mammary carcinoma transfected with human tissue inhibitor of metalloproteinases-1

ONCOLOGY REPORTS; Año: 1998 vol. 5 p. 1083 - 1087

ALONSO, D. F. DE LORENZO, M. S. TEJERA, A. M. GOMEZ, D. E.

Fibrin formation induced by tumor procoagulants enhances urokinase activity produced by mammary carcinoma cells

ONCOLOGY REPORTS; Año: 1998 vol. 5 p. 209 - 212

ALONSO, D F FARINA, H G SKILTON, G GABRI, M R DE LORENZO, M S GOMEZ, D E

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 1998 vol. 50 p. 83 - 93

PONZIO, R ALONSO, D F GOMEZ, D E

Atypical cilia in testicular cells from normal rats

JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY; Año: 1997 vol. 29 p. 313 - 316

GOMEZ, D. E. ALONSO, D. F. YOSHIJI, H. THORGEIRSSON, U. P.

Tissue inhibitors of metalloproteinases: structure, regulation and biological functions

EUROPEAN JOURNAL OF CELL BIOLOGY; Año: 1997 vol. 74 p. 111 - 122

BISGAARD, H C MACKAY, A R GOMEZ, D E TON, P T THORGEIRSSON, S S THORGEIRSSON, U P

Spontaneous metastasis of rat liver epithelial cells transformed with v-raf and v-raf/v-myc: association with different phenotypic properties

Invasion Metastasis; Año: 1997 vol. 17 p. 240 - 250

BISGAARD, H C MACKAY, A R GOMEZ, D E TON, P T THORGEIRSSON, S S THORGEIRSSON, U P

Spontaneous metastasis of rat liver epithelial cells transformed with v-raf and v-raf/v-myc: association with different phenotypic properties

Invasion Metastasis; Año: 1997 vol. 17 p. 240 - 250

THORGEIRSSON, U. P. YOSHIJI, H. SINHA, C. C. GOMEZ, D. E.

Breast cancer; tumor neovasculature and the effect of tissue inhibitor of metalloproteinases-1 (TIMP-1) on angiogenesis

IN VIVO; Año: 1996 vol. 10 p. 137 - 144

THORGEIRSSON, U P SNYDERWINE, E G GOMEZ, D E ADAMSON, R H

Dietary heterocyclic amines as potential human carcinogens: experimental data from nonhuman primates

IN VIVO; Año: 1996 vol. 10 p. 145 - 152

THORGEIRSSON, U. P. GOMEZ, D. E. LINDSAY, C. K. SINHA, C. C. ADAMSON, R. H.

Liver tumors and possible preneoplastic lesions, induced by a food-derived heterocyclic amine in cynomolgus monkeys; a study of histology and cytokeratin expression

LIVER; Año: 1996 vol. 16 p. 71 - 83

LINDSAY, C K GOMEZ, D E THORGEIRSSON, U P

Effect of flavone acetic acid on endothelial cell proliferation: evidence for antiangiogenic properties

ANTICANCER RESEARCH; Año: 1996 vol. 16 p. 425 - 431

COTTAM, D. W. CORBITT, R. H. GOMEZ, D. E. REES, R. C. THORGEIRSSON, U. P.

Alterations in endothelial cell proteinase and inhibitor polarized secretion following treatment with interleukin-1, phorbol ester, and human melanoma cell conditioned medium

JOURNAL OF CELLULAR BIOCHEMISTRY; Año: 1996 vol. 60 p. 148 - 160

YOSHIJI, H. GOMEZ, D. E. THORGEIRSSON, U. P.

Enhanced RNA expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human breast cancer

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 1996 vol. 69 p. 131 - 134

YOSHIJI, H GOMEZ, D E SHIBUYA, M THORGEIRSSON, U P

Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer

CANCER RESEARCH; Año: 1996 vol. 56 p. 2013 - 2016

GOMEZ, D. KASSIM, A. OLIVERO, O.

Preferential incorporation of 3'-azido-2',3'-dideoxythymidine (azt) in telomeric sequences of cho cells

INTERNATIONAL JOURNAL OF ONCOLOGY; Año: 1995 vol. 7 p. 1057 - 1060

GOMEZ, D E NASON, A M THORGEIRSSON, U P

Thrombin treatment of endothelial cells stimulates adhesion of oncogene transformed but not parent rat liver epithelial cells

THROMBOSIS RESEARCH; Año: 1995 vol. 78 p. 87 - 94

RAO, C N GOMEZ, D E WOODLEY, D T THORGEIRSSON, U P

Partial characterization of novel serine proteinase inhibitors from human umbilical vein endothelial cells

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS; Lugar: Amsterdam; Año: 1995 vol. 319 p. 55 - 62

GOMEZ, D. E. YOSHIJI, H. KIM, J. C. THORGEIRSSON, U. P

Ulex europaeus I lectin induces activation of matrix-metalloproteinase-2 in endothelial cells

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; Año: 1995 vol. 216 p. 177 - 182

MACKAY, A R GOMEZ, D E NASON, A M THORGEIRSSON, U P

Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression

LABORATORY INVESTIGATION; Año: 1994 vol. 70 p. 800 - 806

PURICELLI, L. GOMEZ, D. E. VIDAL, M. C. EIJAN, A. M. SPINELLI, O. ALONSO, D. F. DE LUSTIG, E. S. BAL DE KIER JOFFE, E.

Effect of host-organ environment on the in vivo and in vitro behavior of a murine mammary adenocarcinoma

TUMOR BIOLOGY; Año: 1994 vol. 15 p. 284 - 293

GOMEZ, D. E. LINDSAY, C. K. COTTAM, D. W. NASON, A. M. THORGEIRSSON, U. P.

Expression and characterization of human tissue inhibitor of metalloproteinases-1 in a baculovirus-insect cell system

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; Año: 1994 vol. 203 p. 237 - 243

THORGEIRSSON, U P LINDSAY, C K COTTAM, D W GOMEZ, D E

Tumor invasion, proteolysis, and angiogenesis

JOURNAL OF NEURO-ONCOLOGY.; Lugar: Berlin; Año: 1993 vol. 18 p. 89 - 103

MACKAY, A R GOMEZ, D E COTTAM, D W REES, R C NASON, A M THORGEIRSSON, U P

Identification of the 72-kDa (MMP-2) and 92-kDa (MMP-9) gelatinase/type IV collagenase in preparations of laminin and Matrigel

BIOTECHNIQUES; Año: 1993 vol. 15 p. 1048 - 1051

GOMEZ, D. E. HARTZLER, J. L. CORBITT, R. H. NASON, A. M. THORGEIRSSON, U. P.

Immunomagnetic separation as a final purification step of liver endothelial cells

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY. ANIMAL.; Lugar: Berlin; Año: 1993 vol. 29A p. 451 - 455

BONFIL, R D MEDINA, P A GOMEZ, D E FARIAS, E LAZAROWSKI, A LUCERO GRITTI, M F MEISS, R P BUSTUOABAD, O D

Expression of gelatinase/type IV collagenase in tumor necrosis correlates with cell detachment and tumor invasion

CLINICAL & EXPERIMENTAL METASTASIS; Lugar: Berlin; Año: 1992 vol. 10 p. 211 - 220

PURICELLI, L. COLOMBO, L. L. GOMEZ, D. E. VIDAL, M. C. BAL DE KIER JOFFE, E.

Characterization of a new murine tumor variant with different in vivo behavior selected by its adhesive properties

TUMORI; Año: 1990 vol. 76 p. 345 - 349

COLOMBO, L. L. GOMEZ, D. E. PURICELLI, L. VIDAL, M. C. PONZIO, R. BAL DE KIER JOFFE, E.

In vivo selection and characterization of a murine mammary tumor subline with high potential for spontaneous lymph node metastasis

JOURNAL OF SURGICAL ONCOLOGY; Año: 1990 vol. 45 p. 190 - 195

BALLIN, M. GOMEZ, D. E. SINHA, C. C. THORGEIRSSON, U. P.

Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; Año: 1988 vol. 154 p. 832 - 838

PURICELLI, L. I. GOMEZ, D. E. BAL DE KIER JOFFE, E.

Analysis of the metastatic process

MEDICINA (BUENOS AIRES); Año: 1987 vol. 47 p. 313 - 316

HIB J. GOMEZ DE, VILLAR O

Contractile behaviour of rat seminal vesicle after gonadectomy, testosterone replacement and cyproterone treatment.

ANDROLOGIA; Año: 1985 vol. 17 p. 435 - 440